← Back

Crystal Growth & Energy Equipment Co. Ltd. A

Crystal Growth & Energy Equipment Co., Ltd. is a Chinese company engaged in the research, development, production, and sales of crystal growth equipment. Its product lineup includes semiconductor-grade single crystal silicon furnaces, photovoltaic-grade monocrystalline silicon furnaces and control systems, and silicon carbide semiconductor equipment such as single crystal and epitaxial furnaces and thermal consumables. The company also offers crystal processing equipment, including multi-wire cutting machines, fully automatic wafer thinning machines, single-sided polishing machines, and silicon wafer edge polishing systems, as well as other crystal devices like induction heating silicon carbide powder synthesis systems, resistance heating silicon carbide powder systems, aluminum nitride crystal growth equipment, polycrystalline silicon ingot furnaces, silicon carbide coating equipment, HVPE single crystal growth equipment, high-pressure furnace general platforms, and stone multi-wire cutting equipment. Founded in 2012, it is based in Nanjing, China.

Price · split & dividend adjusted
News & notes moving 688478.CG
688478.CG3

Jingsheng Shares Terminates Major Asset Restructuring and Withdraws Application Documents

Jingsheng Shares announced on August 30 that it has decided to terminate the issuance of shares and payment of cash to purchase assets, the related fundraising, and the connected transaction, and to withdraw the application documents. The restructuring was initiated in August 2025 and was called off after about a year. The company had originally planned to acquire 100 percent of Beijing Weizhun Intelligent Technology Co., Ltd., but due to changes in the overall market environment compared with the early stage of the transaction planning, and after prudent consideration and friendly consultation with the transaction parties, it decided to terminate the deal. The company pledged not to plan any major asset restructuring for at least one month from the date of the termination announcement, and plans to hold an investor briefing on September 1. The 2026 semi-annual report disclosed on the same day shows that the company achieved operating revenue of 40.6483 million yuan in the first half of the year, down 41.72 percent year on year. Net profit attributable to shareholders of the listed company was negative 11.7651 million yuan, down 100.04 percent year on year. Despite the earnings pressure, the company maintained high research and development investment, with first-half R&D expenses of 21.0355 million yuan, accounting for 51.75 percent of operating revenue.
每日经济新闻·20dRead more →
688478.CG2

Jingsheng Shares' 2026 Interim Report Shows Net Loss Widening to 11.7651 Million Yuan

Jingsheng Shares released its 2026 interim report, with total operating revenue of 40.6483 million yuan, down 41.72% year-on-year, and net profit attributable to the parent company of negative 11.7651 million yuan, a wider loss than the same period last year. Net cash flow from operating activities was negative 17.5957 million yuan, the asset-liability ratio rose to 16.56%, gross margin was 24.56%, return on equity was negative 0.78%, and diluted earnings per share was negative 0.09 yuan. The company had 14,400 shareholders, and the top ten shareholders held 52.88% of total share capital.
Jiemian·22dRead more →
688478.CG

Tiantong Corporation boosts investment in new soft magnetic materials, Zhonghong Medical net profit surges 2662%

Tiantong Corporation plans to invest 434 million yuan through a wholly-owned subsidiary to build an intelligent manufacturing project with an annual output of 14,600 tonnes of high-end soft magnetic new materials, with a construction period of about 36 months. Zhonghong Medical's net profit attributable to the parent company in the first half of the year surged 2662.38% year-on-year to 159 million yuan. In addition, several companies released half-year reports, with Hangzhou Cable, Yahua Group, and Yongtai Technology all posting substantial net profit growth. Jingsheng Co.'s self-developed large-size CVD SiC chemical vapour deposition coating complete equipment has passed factory inspection and been delivered to customers. Sino Medical's H-share issuance is being filed with the China Securities Regulatory Commission and is expected to be completed in the first quarter of next year; its HT Supreme drug-eluting stent system has been approved in Paraguay. Institutional seats made net purchases of 656 million yuan in Hengtong Optic-Electric and 168 million yuan in Yangtze Optical Fibre and Cable. Wanxun Automation has made progress in its domestic and overseas semiconductor business layout, and Shandong Haode and Anhui Kaize, controlled by Intco Medical, delivered excellent second-quarter profits.
上海证券报·24dRead more →